All Stories

  1. Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19

    Article • Coronaviruses, September 2020, Bentham Science Publishers

    SIVARAMAN D

  2. Current Strategies and Approaches in Combating SARS-CoV-2 Virus that Causes COVID-19

    Article • Letters in Drug Design & Discovery, May 2020, Bentham Science Publishers

    SIVARAMAN D

  3. Bio-active therapeutics targeting SARS-CoV2

    Article • March 2020, MDPI AG

    SIVARAMAN D

  4. Potential antioxidant and anti-inflammatory action of Hypericum hookerianum extracts in a liposome system evaluated with zebrafish embryos

    Article • Journal of Microencapsulation, June 2019, Taylor & Francis

    SIVARAMAN D